Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance

K-Number: K260282 · 2026-04-15

Decision Date2026-04-15
Product CodeLON
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is a medical device manufactured by bioMerieux, Inc.. It received FDA 510(k) clearance on 2026-04-15 under approval number K260282. The device is classified under product code LON. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is a medical device that received FDA 510(k) clearance on 2026-04-15. It is manufactured by bioMerieux, Inc.. The 510(k) number is K260282.

When was VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance approved by the FDA?

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance received FDA 510(k) clearance on 2026-04-15, under approval number K260282.

What company makes VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is manufactured by bioMerieux, Inc..

What is the FDA product code for VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance?

The FDA product code for VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance is LON.

Other Devices by bioMerieux, Inc.

View all 66 devices →

Related Devices (Code: LON)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.